MYDA Advisors’s Strata Critical Medical Inc SRTA Stock Holding History

MYDA Advisors’s Portfolio SRTA Stock Details SRTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-47,000	Closed	-$489K	–	264
2021 Q3	$489K	Sell	47,000 -113,000	-71%	-$987K	0.14%	155
2021 Q2	$1.68M	Buy	+160,000	New	+$1.58M	0.42%	76
2020 Q4	–	Sell	-49,710	Closed	-$500K	–	196
2020 Q3	$500K	Buy	+49,710	New	+$502K	0.26%	75

Other funds holding SRTA

AIM

ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return

HVCM

HG Vora Capital Management New York $191M AUM 1.23% 1-Year Est. Return

NAMA

Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return

Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

AIM

Allen Investment Management New York $8.09B AUM 16.78% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

MYDA Advisors's SRTA Position: Q4 2021 in Review

MYDA Advisors sold out of Strata Critical Medical Inc (SRTA) in Q4 2021, closing a stake of 47,000 shares — an estimated $489K sold.

MYDA Advisors first reported a position in SRTA in Q3 2020 and held it in 3 quarters. The position peaked at $1.68M in Q2 2021. 79 funds tracked by Wall St. Rank hold SRTA as of Q4 2021.

MYDA Advisors reported no remaining Strata Critical Medical Inc position as of Q4 2021 after selling out during the quarter.
MYDA Advisors sold 47,000 Strata Critical Medical Inc shares in Q4 2021, an estimated $489K.
MYDA Advisors first reported a position in Strata Critical Medical Inc in Q3 2020 and held it in 3 quarters.
MYDA Advisors's Strata Critical Medical Inc position peaked at $1.68M in Q2 2021.
79 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q4 2021.

Based on MYDA Advisors's 13F filing for Q4 2021, filed 11 Feb 2022.